Literature DB >> 16964318

New developments in the treatment of attention-deficit/hyperactivity disorder in primary care.

.   

Abstract

Entities:  

Year:  2006        PMID： 16964318      PMCID： PMC1557471     

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  71 in total

Review 1.  Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.

Authors:  Howard Schubiner
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 2.  Molecular genetics of attention-deficit/hyperactivity disorder.

Authors:  Stephen V Faraone; Roy H Perlis; Alysa E Doyle; Jordan W Smoller; Jennifer J Goralnick; Meredith A Holmgren; Pamela Sklar
Journal:  Biol Psychiatry       Date:  2005-01-21       Impact factor: 13.382

Review 3.  Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review.

Authors:  Erik G Willcutt; Alysa E Doyle; Joel T Nigg; Stephen V Faraone; Bruce F Pennington
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382

Review 4.  Isle of Wight revisited: twenty-five years of child psychiatric epidemiology.

Authors:  M Rutter
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1989-09       Impact factor: 8.829

5.  Guanfacine, but not clonidine, improves planning and working memory performance in humans.

Authors:  P Jäkälä; M Riekkinen; J Sirviö; E Koivisto; K Kejonen; M Vanhanen; P Riekkinen
Journal:  Neuropsychopharmacology       Date:  1999-05       Impact factor: 7.853

Review 6.  Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications.

Authors:  Mark L Wolraich; Charles J Wibbelsman; Thomas E Brown; Steven W Evans; Edward M Gotlieb; John R Knight; E Clarke Ross; Howard H Shubiner; Esther H Wender; Timothy Wilens
Journal:  Pediatrics       Date:  2005-06       Impact factor: 7.124

7.  Local infusion of an alpha-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys.

Authors:  Z M Mao; A F Arnsten; B M Li
Journal:  Biol Psychiatry       Date:  1999-11-01       Impact factor: 13.382

8.  Dichotic listening and response inhibition in children with comorbid anxiety disorders and ADHD.

Authors:  K Manassis; R Tannock; J Barbosa
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-09       Impact factor: 8.829

Review 9.  Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD.

Authors:  Russell A Barkley
Journal:  Psychol Bull       Date:  1997-01       Impact factor: 17.737

Review 10.  Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes?

Authors:  Joel T Nigg; Erik G Willcutt; Alysa E Doyle; Edmund J S Sonuga-Barke
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.